ILMN
WATCH Illumina, Inc. · US
—
—
Prices as of close 2026-07-28
Sequencing leader with turnaround potential if growth reaccelerates and sentiment improves.
Buy signals
- ▸Catalyst-sensitive setup, but operating momentum is still rebuilding.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.